Agenus (AGEN) - P/S ratio

P/S ratio as of November 2026 (TTM): 2.44

According to Agenus 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.57. At the end of 2023 the company had a P/S ratio of 2.02.

P/S ratio history for Agenus from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	2.02	-72.93%
2022	7.46	166.81%
2021	2.80	-60.45%
2020	7.07	89.19%
2019	3.74	-51.85%
2018	7.76	1.93%
2017	7.62	-52.1%
2016	15.9	0.62%
2015	15.8	-55.71%
2014	35.7	13.25%
2013	31.5	398.62%
2012	6.32	-59.41%
2011	15.6	-53.6%
2010	33.6	94.8%
2009	17.2	43.57%
2008	12.0	-31.32%
2007	17.5	-85.59%
2006	121	-64.81%
2005	344	-47.14%
2004	652	413.01%
2003	127	27.82%
2002	99.4	-4.86%
2001	104

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.69	174.56%	🇺🇸 USA
Merck MRK	5.43	122.88%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.54	4.13%	🇺🇸 USA
GSK plc GSK	2.26	-7.30%	🇬🇧 UK
Celldex Therapeutics CLDX	> 1000	608,952.32%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Agenus (AGEN)

P/S ratio as of November 2026 (TTM): 2.44